Board of Directors
Elected annually by our shareholders, the Board of Directors is the company's ultimate decision-making body. The directors select and monitor the performance of our senior executives on Bristol Myers Squibb's Leadership Team, who are responsible for the day-to-day operation of the company. Directors also act as advisors and counselors to our senior management.
Giovanni Caforio, M.D.
Chairman of the Board and Chief Executive Officer, Bristol Myers Squibb
Theodore R. Samuels
Lead Independent Director and Retired President of Capital Guardian Trust Company
Peter J. Arduini
President and Chief Executive Officer of Integra LifeSciences Holdings Corporation
Michael W. Bonney
Chair, Kaleido Biosciences, Inc.
Julia A. Haller, M.D.
Ophthalmologist-in-Chief, Wills Eye Hospital
Manuel Hidalgo Medina, M.D., Ph.D.
Chief, Division of Hematology and Medical Oncology, Weill Cornell Medicine and New York-Presbyterian /Weill Cornell Medical Center
Paula A. Price
Former Executive Vice President and Chief Financial Officer, Macy’s, Inc.
Derica W. Rice
Former Executive Vice President, CVS Health and President, Pharmacy Benefits Business, CVS Caremark.
Gerald L. Storch
Chief Executive Officer, Storch Advisors
Karen H. Vousden, Ph.D.
Senior Group Leader, The Francis Crick Institute and Chief Scientist, Cancer Research UK
Phyllis R. Yale
Advisory Partner, Bain & Company